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Resumo
A displasia broncopulmonar (DBP) é multifactorial. 
Prematuridade, doença da membrana hialina, oxi-
génio, ventilação mecânica, inflamação e canal arte-
rial são alguns dos factores na sua patogénese
Objectivo: Avaliar a prevalência da DBP e seus factores 
de risco em cinco unidades portuguesas, para imple-
mentar boas práticas no tratamento deste doentes.
Material e métodos: 256 recém-nascidos (RN) com 
idade gestacional (IG) <30 semanas e/ou peso <1250 g 
internados em cinco unidades portuguesas, entre 
2004 e 2006, foram estudados. Foi recolhida a infor-
mação clínica dos processos. A DBP foi definida 
como a necessidade de oxigénio às 36 semanas de 
idade pós-conceptional.
Abstract
The pathogenesis of bronchopulmonary dysplasia 
(BPD) is clearly multifactorial. Specific pathogenic 
risk factors are prematurity, respiratory distress, oxy-
gen supplementation, mechanical ventilation (MV), 
inflammation, patent ductus arteriosus (PDA), etc.
Aim: To evaluate BPD prevalence and to identify risk 
factors for BPD in five Portuguese Neonatal Inten-
sive Care Units in order to develop better practices 
the management of these newborns.
Material and methods: 256 very low birth weight in-
fants with gestational age (GA) <30 weeks and/or 
birthweight (BW) <1250 g admitted in five Portuguese 
NICUs, between 2004 and 2006 were studied. A pro-
tocol was filled in based on clinical information regis-
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Resultados: A prevalência da DBP foi de 12,9%. O 
seu risco diminuiu de 46% por semana de IG e de 
39% por 100g de peso. O risco de DBP foi maior 
entre os RN com baixo peso (OR adj = 0,73, 95% 
CI=0,57-0,95), doença da membrane hialina grave 
(OR adj = 9,85, 95% CI=1,05-92,35), com sépsis 
(OR adj = 6,22, 95% CI=1,68-23,02), com maior 
duração de ventilação (42 vs 3 dias, respectivamente 
nos RN com e sem DBP, p<0,001) e maior duração 
de FiO2>0,30 (85 vs 5 dias, respectivamente nos 
doentes com e sem DBP, p<0,001).
Comentários: Os factores de risco de DBP mais re-
levantes foram o baixo peso, a doença da membrana 
hialina grave, a duração da ventilação mecânica e da 
oxigenoterapia e a sépsis. A implementação das boas 
práticas para reduzir a lesão pulmonar nos RN deve 
ser dirigida para melhorar as práticas que reduzem es-
tes factores de risco.
Rev Port Pneumol 2010; XVI (3): 419-430
Palavras-chave: Displasia broncopulmonar, recém-nas-
cidos pré-termo, unidades de cuidados intensivos neo-
natais, doença da membrana hialina, ventilação mecâni-
ca, oxigenoterapia, factores de risco, boas práticas.
tered in the hospital charts. BPD was defined as oxy-
gen dependency at 36 weeks of postconceptional age.
Results: BPD prevalence was 12.9% (33/256). BPD 
risk decreased 46% per GA week and of 39% per 100g 
BW. BPD risk was significantly higher among new-
borns with low BW (adj OR= 0.73, 95% CI=0.57-
0.95), severe hyaline membrane disease (adj OR= 9.85, 
95% CI=1.05-92.35), and those with sepsis (adj 
OR=6.22, 95% CI=1.68-23.02), those with longer 
duration on ventilatory support (42 vs 3 days, respec-
tively in BPD and no BPD patients, p<0.001) and lon-
ger duration of FiO2>0.30 (85 vs 5 days, respectively 
in BPD and no BPD patients, p<0.001).
Comments: The most relevant risk factors were low 
birth weight, severe hyaline membrane disease, dura-
tion of respiratory support and oxygen therapy, and 
nosocomial sepsis. The implementation of potentially 
better practices to reduce lung injury in neonates 
must be addressed to improve practices to decrease 
these risk factors.
Rev Port Pneumol 2010; XVI (3): 419-430
Key-words: Bronchopulmonary dysplasia, preterm 
infants, neonatal intensive care, prematurity, hyaline 
membrane disease, mechanical ventilation, oxygen 
therapy, risk factors, better practices.
Introduction
The pathogenesis of Bronchopulmonary 
dysplasia (BPD) is clearly multifactorial and 
specific pathogenic known risk factors are 
prematurity, hyaline membrane disease 
(HMD), oxygen supplementation, mecha-
nical ventilation (MV), inflammation and 
infection, patent ductus arteriosus (PDA), 
among others1. Despite extensive research 
aimed at identifying risk factors of BPD and 
devising preventative therapies, many ques-
tions about the aetiology and pathogenesis 
of BPD remain2.
With the advent of surfactant, prenatal ste-
roids and improving technology, the sur-
vival rate of extremely low birth weight 
(ELBW) infants has improved dramatically. 
Despite these improvements, however, the 
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incidence of BPD in ELBW infants has re-
mained stable over last decades and contri-
butes significantly to the morbidity and 
mortality seen in these preterm infants. 
Rates of BPD vary widely. In a recent study, 
where BPD was defined as oxygen need at 
36 weeks postconceptional age, the inci-
dence was 52% in infants with birth weight 
of 501-750g, 34% in infants with birth 
weight of 751-1000g, 15% in infants with 
birth weight of 1001-1200g, 7% in infants 
with birth weight of 1201-1500g3.
In these very preterm babies, BPD (New 
BPD) is quite different from the BPD des-
cribed in the most mature babies (Old or 
Classic BPD), because the delivery occurred 
in the very immature stage of the normal 
lung development4-6. This can explain the 
histological characteristic features showing 
rarefaction of the pulmonary vascular bed, 
reduced alveolarization, less fibrosis and less 
bronchial metaplasia. In this “New” PBD 
the immaturity seems to be much more im-
portant than external factors. However oxy-
gen toxicity, volu and barotrauma of me-
chanical ventilation, inflammation and/or 
infection (biotrauma) and increased pulmo-
nary flow and lung oedema are also very im-
portant risk factors to be taken into account 
in these immature babies1.
Our aim was to evaluate the prevalence of 
BPD and to identify risk factors for BPD in 
preterm babies of five Portuguese NICUs in 
order to develop better practices in the man-
agement of these newborns.
Patients and methods
Very low birth weight (VLBW) infants with 
gestational age (GA) less than 30 weeks and/
or birth weight (BW) less than 1250 grams 
admitted in five Portuguese NICUs, be-
tween 1st January 2004 and 31st December 
2006 and alive at 36 weeks of PCA were in-
cluded. VLBW infants with major malfor-
mations, grade IV intraventricular haemor-
rhage in the first week of life, metabolic or 
neuromuscular disease were excluded. A 
protocol was filled in based on clinical in-
formation registered in the hospital charts: 
maternal history, newborn demographical 
and clinical data, mechanical ventilation 
(MV), oxygen supplementation and fluid 
administration until 36 weeks of postcon-
ceptional age (PCA). Neonatal sepsis, pat-
ent ductus arteriosus (PDA), necrotizing 
enterocolitis (NEC), retinopathy of prema-
turity (ROP), intraventricular haemorrhage 
(IVH), periventricular leukomalacia (PVL) 
were also registered.
BPD was defined as oxygen dependency at 
36 weeks of PCA and had characteristic 
chest radiographs7. Gestational age (in this 
study we considered the completed weeks) 
was assessed by menstrual age (women with 
regular menstrual cycles), ultrasound exami-
nation (when a discrepancy of two or more 
weeks existed between the age derived by 
menstrual dating and the age derived sono-
graphically, or in the absence of a menstrual 
date)8 or the New Ballard Score (in the ab-
sence of obstetrical indexes)9. Respiratory 
distress syndrome (hyaline membrane di-
sease) was defined according to Rudolf AJ et 
al criteria10. Proven neonatal sepsis was de-
fined as any systemic bacterial or fungal in-
fection documented by a positive blood cul-
ture. Hemodynamically significant patent 
ductus arteriosus was diagnosed on the basis 
of the echocardiographic findings. The cri-
teria of Bell were used for the diagnosis and 
staging of necrotizing enterocolitis11. Stag-
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ing of retinopathy of prematurity was done 
according to the International Classifica-
tion12,13. Intraventricular haemorrhage was 
classified according to Papile LA14. Periven-
ticular leukomalacia was classified accord-
ing to de Vries L and Rennie JM15.
Odds ratios were used to measure the mag-
nitude of the association between BPD and 
BPD risk factors. Crude and adjusted Odds 
ratios were calculated using unconditional 
logistic regression.
The Breslow-Day and Taron’s statistics were 
computed for the test of homogeneity of 
the odds ratios among the five hospitals.
A p value <0.05 was considered significant.
Statistical analysis was performed using the 
statistical package SPSS 17.0.
Results
A sample of 256 newborns met inclusion 
criteria. We observed a decrease in BPD risk 
of 46% per week of GA and of 39% per 
100g BW. The prevalence of BPD was 
12.9% (33/256).
Out of 256 infants, 143 (56%) had HMD. 
Two (6.7%) infants without HMD and in 
81 (41.3%) with HMD developed BPD.
The risk of BPD was higher among preterm 
infants with low GA (crude OR=054, 95% 
CI=0.43-0.70); low birth weight (crude 
OR=0.61, 95%CI=0.50-0.74); intrauterine 
growth restriction (crude OR=1.23, 
95%CI=0.50-3.04), those with HMD 
(crude OR=7.15, 95%CI=1.48-34.41, for 
mild HMD; crude OR=9.72, 95%CI 2.09-
45.24, for moderate HMD and crude 
OR=20.25, C95%CI=3.81-107.65, for se-
vere HMD), ventilated newborns (crude 
OR=5.97, 95%CI=1.39-25.7), those with 
FiO2>0.4 (3.92, 95%CI=1.60-9.58), with 
higher daily mean fluid administration 
(crude OR=1.01, 95%CI=1.01-1.10) and 
those with nosocomial sepsis crude 
(OR=6.41, 95%CI=2.54-16.14) and PDA 
(crude OR=4.48, 95%CI=2.10-9.58). After 
adjustment for all variables in the model, 
only OR for birth weight, severe HMD and 
sepsis (early and late or nosocomial) were 
significantly associated with BPD (Table I).
The median of the duration of mechanical 
ventilation was 42 days in BPD patients and 
3 in non BPD patients, p<0.001. The me-
dian of the duration of oxygen therapy was 
85 days in PBD patients and 5 in non BPD 
patients, p<0.001 (Table II).
From the associated pathology we looked 
for (NEC, ROP; IVH and PVL) only ROP 
was significantly associated with BPD, 
p<0.001 and OR=3.48 (Table III).
Discussion
Despite increased knowledge and improv-
ing technology, BPD rates have remained 
high. Its incidence varies among institu-
tions, ranging between 15 and 50% of all 
VLBW infants16. These differences can be 
due in part to the definition of BPD and to 
the decision to administer oxygen that is 
not uniform, because there is no consensus 
in the literature and neonatologists have 
widely divergent practices regarding oxygen 
saturations targets. In this study we used the 
BPD definition of oxygen dependency at 36 
weeks of PCA.
To decrease the big differences, efforts must 
be made to identify infants treated with ox-
ygen who are able to maintain saturations 
exceeding 90% in room air17,18. After 4 de-
cades since the original description by 
Northway, its clinical presentation, evidence 
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about its pathogenesis and epidemiology 
have changed and the understanding of this 
process has provided new possibilities for 
BPD prevention.
The prevalence of BPD in our study was 
12.9%; a similar frequency of 15% has been 
published in infants with birth weight of 
1001-1200g3. In VLBW infants Portugal 
the frequency of BPD is of 20 %19. How-
ever these frequencies must be compared 
taking into account the mortality rate ob-
served in these NICUs. In this study the 
global rate of mortality in this group of pre-
term infants was 17.8%.
The incidence of BPD in premature infants 
is inversely proportional to gestational age 
and birth weight16,20. We observed a decrease 
in BPD risk of 46% per GA week and of 
39% per 100g BW; we found no significant 
difference between sexes.
Table I – Bronchopulmonary risk factors
BPD n=33 no BPD n=223 Crude OR (95% CI) Adjusted OR* (95% CI)
Gestational age (weeks) P50 (P25-P75) 26 (25-27) 29 (27-29) 0.54 (0.43-0.70) 0.84 (0.59-1.16)
Birth weight (grams) P50 (P25-P75) 770 (700-990) 1120 (930-1250) 0.61 (0.50-0.74) 0.73 (0.57-0.95)
Sex (M/F) 17/16 114/109 0.98 (0.47-2.05) –
Clinical chorioamnionitis 3 (9%) 51 (22.8%)  0.35 (0.10-1.21) –
Intrauterine growth restriction 7 (21.2%) 40 (17.9%)  1.23 (0.50-3.04) –
Mild HMD 9 (30) 51 (26) 7.15 (1.48-34.41) 3.9 (0.54-28.84)
Moderate HMD 12 (40) 50 (25.5) 9.72 (2.09-45.24) 3.28 (0.40-2.18)
Severe HMD 7 (23.3) 14 (7.1) 20.25 (3.81-107.65) 9.85 (1.05-92.35)
Mechanical ventilation 31 (93.9%) 161 (72.2%) 5.97 (1.39-25.7)  0.45 (0.51-4.08)
FiO2 >0.40 22 (66.6%) 93 (41.7%) 3.92 (1.60-9.58)  0.87 (0.24-3.13)
Fluids, 1st week, ml/kg/day (P25-P75) 114 (84-145) 111 (77-146) 1.05 (1.01-1.10)  1.01 (0.95-1.07)
Early and late sepsis 27 (81.8%) 92 (41.3%) 6.41 (2.54-16.14)  6.22 (1.68-23.02)
Patent ductus arteriosus 22 (66.6%) 77 (34.5%) 4.48 (2.10-9.58)  2.54 (0.82-7.85)
* Adjusted for all variables in the model. MV – mechanical ventilation; HMD – Hyaline membrane disease
Table II – Duration of mechanical ventilation and FiO2 in patients with and without BPD
BPD 
(n=33)
no BPD 
(n=223) p
Mechanical ventilation, days (P25-75)  42 (25-63) 3 (0-8) <0.001
FiO2, days (P25-75)  85 (71-100) 5 (2-30) <0.001
Table III – Associated pathology with bronchopulmonary dysplasia
BPD n (%) No BPD n (%) p crude OR (95% CI) adjusted OR* (95% CI)
NEC (>IIA) (3.0) 3 (1.3) 0.420 – –
ROP (>3) 8 (24.2) 8 (3.6) <0.001 8.6 (2.97-24.92) 3.48 (1.06-11.41)
IVH (III-IV) 2 (6.1) 13 (5.8) 1.000 – –
PVL 1 (3.0) 12 (5.4) 1.000 – –
* Adjusted for gestational age and birth weight. NEC – necrotizing enterocolitis; ROP – retinopathy of prematurity; IVH – intraventricular haemorrhage; PVL – periventricular 
leukomalacia
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Chorioamnionitis – Inflammation (and in-
fection), either antenatal or postnatal, is like-
ly to be a major trigger for the lung inflam-
mation that plays a role in the pathogenesis 
of BPD1,21,22. Airways remodelling can occur 
as a consequence of lung injury23,24.
Although there is a recent evidence that pre-
mature infants born to mothers with chori-
oamnionitis are at increased risk of develop-
ing BPD21,23, other studies couldn’t confirm 
this association25,26. In this study chorioam-
nionitis was not analysed because placental 
histological data, essential for the chorioam-
nionitis diagnosis, were missing in many 
patients’ charts.
Intrauterine growth restriction – Preterm 
infants with intrauterine growth retardation 
(IUGR) reveal an increased risk of perinatal 
mortality and neonatal morbidity, namely 
for the development of acute and chronic 
pulmonary disorders, i.e. BPD20,27-28. Ano-
ther recent study showed that AGA infants 
of 26-28 weeks’ gestation with birth weights 
below the median had an increased risk of 
developing BPD29.
In this study, IUGR was not identified as a 
risk factor of BPD, registered in 21.2% and 
17.9% of the babies, respectively with and 
without the disease. This may be due in part 
to the fact of the small size of the sample to 
identify risk factors of this multifactorial 
disease. However, a recent study shows that 
the most significant va riable that can be 
correlated to the long-term outcome is the 
gestational age20.
Hyaline membrane disease – HMD or res-
piratory distress syndrome is a common 
cause of morbidity and mortality associated 
with premature delivery. In uncomplicated 
cases, typically seen in more mature infants, 
recovery is rapid and infants generally no 
longer require oxygen or ventilatory sup-
port after the first week of life. The most 
premature infants are at greatest risk of se-
vere RDS and frequently develop complica-
tions, including central nervous system hae-
morrhage, PDA, air leak, and infection, 
which contribute to prolonged require-
ments of oxygen and ventilatory support 
and consequently preterm infants develop 
BPD30. BPD rarely develops, nowadays, in 
infants greater than 32 weeks of gestation, 
being inversely proportional to GA and 
BW16. The present study shows, as we ex-
pected, that severe HMD was significantly 
associated with BPD. The increased vulne-
rability of extremely preterm infants relates 
to the immature state of the lung develop-
ment that can be easily damaged by me-
chanical ventilation and oxygen, required to 
ensure survival. The premature birth plus 
therapeutic interventions can disrupt the 
normal progression of lung architecture, re-
lated to the development of alveoli and lung 
vasculature. This produces significant se-
quelae, inhibition of acinar development 
and reduction in number of alveoli and ca-
pillaries, seen in the “New” BPD. In both, 
Classic and New BPD the lung immaturity 
is a major BPD risk factor1.
Mechanical ventilation – Invasive ventila-
tion via the endotracheal tube is one of the 
most common therapeutic interventions 
performed in preterm infants with respira-
tory failure. Mechanical ventilation using 
conventional or high-frequency ventilation 
and surfactant therapy have become the 
standard of care in management of preterm 
infants with RDS. However, BPD remains 
as a major morbidity with adverse pulmo-
nary and non pulmonary outcomes in pre-
term infants despite these interventions. 
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Ventilator-associated lung injury appears to 
be related to the duration of invasive venti-
lation via the endotracheal tube rather than 
the mode of ventilation. Randomized con-
trolled trials comparing conventional me-
chanical ventilation and high-frequency 
ventilation, using ‘optimal ventilatory strat-
egies’, have shown no significant difference 
in rates of BPD. Use of noninvasive ventila-
tion, such as N-CPAP has shown a signifi-
cant decrease in post extubation failure as 
well as reduced incidence of BPD31-33.
In the present study the risk of BPD was 
significantly higher among ventilated new-
borns, but after adjustment for all variables 
in the model in MV the difference was not 
statistically significant (Table I). However 
the median of the duration of mechanical 
ventilation was 42 days in BPD patients and 
3 in non BPD patients, p<0.001 (Table II). 
This aspect confirms the importance of MV 
as a risk factor of BPD and should be taken 
into account in the management of these 
preterm infants.
N-CPAP or early surfactant therapy with 
early extubation onto N-CPAP rather than 
continued mechanical ventilation has been 
adopted by many centres, particularly in 
Scandinavia, as part of the treatment of 
newborns with respiratory distress syn-
drome. It has been suggested that BPD is 
less of a problem in centres adopting such a 
policy. Results from randomized trials sug-
gest prophylactic or early N-CPAP may re-
duce BPD, but further studies are required 
to determine the relative contributions of 
an early lung recruitment policy, early sur-
factant administration and N-CPAP in re-
ducing BPD. In addition, the optimum 
method of generating and delivering N-
CPAP needs to be determined. The efficacy 
of N-CPAP in improving long-term respira-
tory outcomes needs to be compared with 
the newer ventilator techniques with the 
optimum and timing of delivery of surfac-
tant administration34,35.
Oxygen – Oxygen is the most commonly 
used therapy in NICUs as an integral part of 
respiratory support. The objective of oxygen 
therapy is to achieve adequate delivery of 
oxygen to the tissue without creating oxygen 
toxicity. However current evidence for opti-
mal oxygen saturation for extremely prema-
ture infants is scarce. We still know very little 
about how much oxygen these babies actua-
lly need, or how much oxygen is safe to give, 
especially in the first few weeks of life35-38.
In the STOP-ROP trial (Supplemental 
Therapeutic Oxygen for Prethreshold Reti-
nopathy), babies in supplemental oxygen 
arm (target saturations of 96-99%) had evi-
dence of adverse pulmonary outcome com-
paring with the conventional oxygen arm 
(target saturations of 89-94%)39.
Recent studies of Saugstad and co-workers 
showed that in ELBW infants, oxygen satu-
rations levels should be kept between 85 
and 93% or possibly between 88 and 95%, 
but should definitely not exceed 95% and 
fluctuations should be avoided35.
In this study the risk of BPD was significant-
ly higher among newborns with FiO2>0.4, 
but after adjustment for all variables in the 
model, the difference was no longer statisti-
cally significant (Table I). However the me-
dian of the duration of oxygen therapy was 
85 days in PBD patients and 5 in no BPD 
patients, p<0.001 (Table II). This aspect 
confirms the importance of the high FiO2 as 
risk factor of BPD and should be taken into 
account in the management of these preterm 
infants.
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To avoid hyperoxemia is an important goal 
during respiratory support and neonatal ex-
posure to 100% oxygen is almost never ne-
cessary. Much lower FiO2 during the neona-
tal period can also lead to oxygen toxicity if 
oxygen is used when it is not necessary. Even 
brief neonatal exposures to pure oxygen 
must be avoided40.
Recent data show that a lower FIO2, less 
than 0.45, confers greater advantage in re-
ducing the incidences of air leak syndromes 
and BPD comparing with a higher FIO2 
(more than 0.45), in the treatment of 
RDS21.
Fluids – We couldn’t identify fluids admi-
nistration as a risk factor of BPD in our pa-
tients. The risk of BPD was significantly 
higher among newborns with higher daily 
mean fluid administration, but after adjust-
ment for all variables in the model, the dif-
ference was not statistically significant (Ta-
ble I). This may be due in part to the fact of 
the small size of the sample to identify risk 
factors of this multifactorial disease. How-
ever the excessive fluid intake and/or de-
creased early weight loss and prolonged 
PDA are major pathogenic mechanisms for 
BPD well known. Infants with BPD have 
increased lung water and are susceptible to 
gravity-induced collapse and alveolar flood-
ing in the dependent lung with focal tissue 
damage being distributed inhomogenously. 
High fluid volumes in the first days of life 
may increase neonatal morbidity, being as-
sociated to increased risk of PDA. Therefore 
fluid restriction is a standard treatment in 
the care of the premature infant, with the 
goal of reducing BPD risk31,41-44.
Neonatal sepsis – The presence of nosoco-
mial infections during the first month of life 
increases the risk of BPD in preterm infants 
requiring prolonged mechanical ventilation, 
another risk factor to the disease45,46. Neo-
natal infection increased also the risk of late 
death, neurosensory impairment and in ex-
tremely low birth weight infants47.
In our study, nosocomial sepsis was ob-
served in 81.8% of preterm infants with 
BPD and in 41.3% of preterm infants with-
out the disease, OR=6.41, 95% CI=2.54-
16.14, (Table I). The national average of 
sepsis in VLBW infants is 35 %19. Rates of 
early– and late-onset septicaemia of 5% and 
29.4%, respectively, were recently published 
in VLBW infants48.
It is crucial to reduce neonatal sepsis in our 
preterm infants in all NICUs. As neonatal 
sepsis is significantly associated with BPD 
in our patients, in decreasing sepsis we can 
decrease BPD rate in Portuguese preterm 
infants. (Table I). With the increasing sur-
vival of extremely premature infants there 
are a large number of them who are devel-
oping chronic lung disease, but the severity 
of the lung damage is considerably less than 
that observed in the classic form of BPD. 
Many of these infants have only a mild ini-
tial respiratory distress and therefore do not 
receive aggressive ventilation. So it seems 
that factors other than oxygen toxicity and 
mechanical ventilation are involved in the 
pathogenesis of this new milder type of 
BPD1,45.
Patent ductus arteriosus – In this study the 
risk of BPD was significantly higher among 
newborns with PDA (crude OR=4.48, 
95%CI=2.10-9.58), but after adjustment 
for all variables in the model, the difference 
was no longer statistically significant (Table 
I). This may be due in part to the fact of the 
small size of the sample to identify risk fac-
tors of this multifactorial disease.
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Clinical and epidemiological data strongly 
suggest that the presence of a PDA plays a ma-
jor role in the development of BPD in these 
infants and accounts for significant morbidity 
in preterm newborns49. For this reason, efforts 
to prevent BPD in extremely low birth weight 
infants should include an aggressive approach 
to an early closure of the PDA hemodynami-
cally significant50-53. However it has also been 
assessed that in randomized control trials, nei-
ther a significant reduction, nor even a trend 
towards a reduction on BPD was observed54.
Major pathology – In major pathology we 
included NEC (grade > IIA), ROP (grades 
>3), IVH (grades 3-4) and PVL, because of 
the few cases in the sample. The major pa-
thology observed in our patients was signifi-
cantly different among the centers
In our study, from the BPD associated pa-
thology (NEC, ROP; IVH and PVL) we 
looked for, only ROP was significantly as-
sociated with BPD, p<0.001, adjusted 
OR=3.48, 95%CI=1.06-11.41 (Table III).
In VLBW infants in Portugal, we found 
IVH in 27 %, NEC in 10 %, ROP in 9 %, 
PVL in 6 %, of preterm infants less than 
1500 grams19.
In a recent Spanish study, intraventricular 
haemorrhage grades 3 to 4 (8.1%) and cys-
tic leukomalacia (2.6%) were the most re-
levant brain ultrasound findings and NEC 
was observed in 6.9% of VLBW infants48.
In a 10 years period, to investigate trends in 
mortality and morbidity in very preterm in-
fants there were no changes in the rates of 
IVH (grades 3-4), ROP (grades > 3), sei-
zures or NEC (grade > IIA. The increasing 
rate of sepsis was present in infants <28 ges-
tational weeks, whereas the increase in BPD 
was demonstrated in the whole study popu-
lation <32 gestational weeks49.
Comments
Bronchopulmonary dysplasia has been in-
creasing over the past two decades in paral-
lel with an improvement in the survival 
ELBW infants. It stems from the interac-
tion of multiple factors that can damage the 
immature lung. For this reason prevention 
must be based on the elimination of all the 
factors implicated in its pathogenesis.
Our data show that in the five centers of the 
study the prevalence of BPD was 12.9% 
(33/256) and the most relevant risk factors 
identified were low birth weight, severe 
HMD, duration of MV, duration of oxygen 
therapy and neonatal sepsis.
The implementation of potentially better 
practices to reduce lung injury in neonates 
in Portuguese NICUs must be addressed to 
decrease HMD, mechanical ventilation, 
oxy gen therapy and the prevalence of sepsis.
However all NICUs must keep making ef-
forts to assure known better practices, de-
creasing risk factors and contributing to 
BPD prevention55-57.
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